Sarepta Therapeutics, Inc. (SRPT)
17.50
-0.07
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
17.50
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Profit Margin (Quarterly) : -1.22% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.22% |
| March 31, 2026 | 45.29% |
| December 31, 2025 | -93.07% |
| September 30, 2025 | -45.06% |
| June 30, 2025 | 32.22% |
| March 31, 2025 | -60.08% |
| December 31, 2024 | 24.16% |
| September 30, 2024 | 7.19% |
| June 30, 2024 | 1.78% |
| March 31, 2024 | 8.74% |
| December 31, 2023 | 11.51% |
| September 30, 2023 | -12.34% |
| June 30, 2023 | -9.16% |
| March 31, 2023 | -203.8% |
| December 31, 2022 | -42.27% |
| September 30, 2022 | -111.9% |
| June 30, 2022 | -99.14% |
| March 31, 2022 | -49.82% |
| December 31, 2021 | -60.55% |
| September 30, 2021 | -25.42% |
| June 30, 2021 | -49.61% |
| March 31, 2021 | -113.8% |
| December 31, 2020 | -130.4% |
| September 30, 2020 | -136.5% |
| June 30, 2020 | -109.8% |
| Date | Value |
|---|---|
| March 31, 2020 | -15.39% |
| December 31, 2019 | -235.4% |
| September 30, 2019 | -127.5% |
| June 30, 2019 | -292.0% |
| March 31, 2019 | -88.08% |
| December 31, 2018 | -166.9% |
| September 30, 2018 | -97.33% |
| June 30, 2018 | -148.6% |
| March 31, 2018 | -54.74% |
| December 31, 2017 | -41.90% |
| September 30, 2017 | -103.9% |
| June 30, 2017 | -180.1% |
| March 31, 2017 | |
| December 31, 2016 | -1.63K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -5.16K% |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -164.5K% |
| September 30, 2014 | -2.76K% |
| June 30, 2014 | -1.31K% |
| March 31, 2014 | -464.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -539.3% |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Beam Therapeutics, Inc. | -25.04K% |
| ImmunityBio, Inc. | -449.6% |
| Twist Bioscience Corp. | -29.61% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -19.42% |
| Return on Assets | -7.88% |
| Return on Invested Capital | -10.58% |
| Gross Profit Margin (Quarterly) | 60.18% |
| Operating Margin (Quarterly) | 13.03% |
| Return on Net Operating Assets | -13.22% |